SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOndine Biomed Regulatory News (OBI)

Share Price Information for Ondine Biomed (OBI)

Share Price is delayed by 15 minutes
Get Live Data
13.00    0.25 (1.96%)
Bid:
12.50
Ask:
13.50
Spread: 1.00 (8.00%)
Market Cap: £67.54m
OBI Live PriceLast checked at - London Stock Exchange

Intraday Ondine Biomed Share Chart

Date   Source Headline
22nd Nov 20248:30 amRNSDirector Holdings
18th Nov 20245:00 pmRNSNOTIFICATION OF MAJOR HOLDINGS
15th Nov 20243:30 pmRNSFinal Result of Fundraise & TVR
14th Nov 20247:00 amRNSUpdated Result of Fundraise
11th Nov 20247:00 amRNSUpdate on Private Placement and Placing
1st Nov 20243:34 pmRNSResult of Fundraise
1st Nov 20247:00 amRNSProposed Fundraise
30th Oct 20245:30 pmRNSRelated Party Transaction
23rd Oct 20247:00 amRNSKing’s College Hospital to run Steriwave pilot
30th Sep 20247:07 amRNSOndine Biomedical Reports Robust Growth in H1 2024
25th Sep 20247:00 amRNSCollaboration advances Steriwave for ICU Market
24th Sep 20247:29 amRNSOndine secures C$5 million financing
23rd Sep 20247:00 amRNSMölnlycke® and Ondine Join Forces Against HAIs
16th Sep 20247:00 amRNSRelated Party Transaction
16th Sep 20247:00 amRNSOndine announces Board Changes
6th Aug 20247:00 amRNSLeeds Teaching Hospital NHS Trust to use Steriwave
28th Jun 20245:45 pmRNSResult of AGM and Voting Results
7th Jun 20247:00 amRNS2023 Full Year Results and Annual Report
6th Jun 20247:00 amRNSNotice of AGM and Directorate Change
28th May 20247:00 amRNSNotice of Results, Investor Presentation, and AGM
13th May 20249:30 amRNSNOTIFICATION OF MAJOR HOLDINGS
10th May 20247:00 amRNSECDC report shows rising HAIs and antibiotic use
8th May 20247:00 amRNSFurther Result of Fundraising
3rd May 20244:27 pmRNSResult of Fundraising
3rd May 20248:00 amRNSOndine announces proposed fundraising
2nd May 20246:25 pmRNSRelated Party Transactions
25th Apr 20247:00 amRNSNew study confirms nose is key source of infection
24th Apr 20247:00 amRNSCorporate and Trading Update
22nd Apr 20247:00 amRNSSteriwave in first Australian hospital
15th Apr 20247:00 amRNS32% Fewer SSIs After Steriwave Replaced Mupirocin
10th Apr 20247:00 amRNSSteriwave authorized for use by HCA UK
4th Apr 20247:00 amRNSEntry into ICU market expands revenue potential
28th Mar 202412:52 pmRNSAppointment of Interim Chief Financial Officer
25th Mar 20247:00 amRNSFirst commercial adoption of Steriwave by the NHS
21st Mar 20247:00 amRNSSteriwave study shows 77% drop in antibiotic use
15th Mar 20245:10 pmRNSReplacement: Steriwave deploying in 8 new sites
15th Mar 20247:00 amRNSSteriwave deploying in eight new sites
5th Mar 20249:45 amRNSOndine starts first UK health economics study
31st Jan 20247:00 amRNSMicrobiome research supports use of Steriwave
26th Jan 20247:00 amRNSOndine unveils new research at SPIE Photonics West
26th Jan 20247:00 amRNSGrant of Share Options
16th Jan 20248:15 amRNSAppointment of new Chief Financial Officer
13th Dec 20237:00 amRNSC$4.91 raise supports ongoing commercialisation
12th Dec 20231:20 pmRNSTR-1: NOTIFICATION OF MAJOR HOLDINGS
11th Dec 20236:15 pmRNSResult of Fundraising
5th Dec 20237:00 amRNSResult of Placing & Broker Option Update
4th Dec 20231:28 pmRNSClose of Bookbuild
1st Dec 20236:13 pmRNSUpdate. Re investor-led financing
30th Nov 20236:40 pmRNSOndine announces investor-led financing
16th Nov 20237:00 amRNSPhotodisinfection recommended as Standard of Care

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.